DE69940922D1 - Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on - Google Patents

Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on

Info

Publication number
DE69940922D1
DE69940922D1 DE69940922T DE69940922T DE69940922D1 DE 69940922 D1 DE69940922 D1 DE 69940922D1 DE 69940922 T DE69940922 T DE 69940922T DE 69940922 T DE69940922 T DE 69940922T DE 69940922 D1 DE69940922 D1 DE 69940922D1
Authority
DE
Germany
Prior art keywords
cyclopropylmethoxy
methylsulfonyl
dimethyl
furan
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940922T
Other languages
English (en)
Inventor
Beatrice Calais
Evelyne Chassagneux
Jean-Michel Bonard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Merial SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial SAS filed Critical Merial SAS
Application granted granted Critical
Publication of DE69940922D1 publication Critical patent/DE69940922D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
DE69940922T 1999-10-08 1999-10-08 Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on Expired - Lifetime DE69940922D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99402482A EP1090915B1 (de) 1999-10-08 1999-10-08 Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-¬4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on

Publications (1)

Publication Number Publication Date
DE69940922D1 true DE69940922D1 (de) 2009-07-09

Family

ID=8242136

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940922T Expired - Lifetime DE69940922D1 (de) 1999-10-08 1999-10-08 Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on

Country Status (12)

Country Link
US (1) US6677373B2 (de)
EP (1) EP1090915B1 (de)
JP (1) JP4805505B2 (de)
AT (1) ATE432269T1 (de)
AU (2) AU774172C (de)
CA (1) CA2386549C (de)
CY (1) CY1110062T1 (de)
DE (1) DE69940922D1 (de)
DK (1) DK1090915T3 (de)
ES (1) ES2326849T3 (de)
PT (1) PT1090915E (de)
WO (1) WO2001027097A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2417019T3 (es) 2003-11-13 2013-08-05 University Of Georgia Research Foundation, Inc. Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
US7151158B2 (en) * 2004-01-30 2006-12-19 General Electric Company Method of preparing a poly(arylene ether), apparatus therefor, and poly(arylene ether) prepared thereby
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
UA57002C2 (uk) * 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
ATE212343T1 (de) * 1995-10-30 2002-02-15 Merck Frosst Canada Inc 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren
AU710675B2 (en) * 1996-02-01 1999-09-30 Merck Frosst Canada Ltd. Alkylated styrenes as prodrugs to COX-2 inhibitors
ES2201466T3 (es) * 1997-03-14 2004-03-16 MERCK FROSST CANADA & CO. `(metilsulfonil)fenil-2-(5h)-furanonas con enlace con oxigeno como inhibidores de cox-2`.

Also Published As

Publication number Publication date
WO2001027097A1 (en) 2001-04-19
JP4805505B2 (ja) 2011-11-02
AU2004206979A1 (en) 2004-09-30
JP2003511443A (ja) 2003-03-25
ATE432269T1 (de) 2009-06-15
US6677373B2 (en) 2004-01-13
EP1090915A1 (de) 2001-04-11
AU774172C (en) 2005-06-09
ES2326849T3 (es) 2009-10-20
US20030050337A1 (en) 2003-03-13
AU774172B2 (en) 2004-06-17
AU7921800A (en) 2001-04-23
CA2386549C (en) 2010-09-21
PT1090915E (pt) 2009-08-03
CA2386549A1 (en) 2001-04-19
CY1110062T1 (el) 2015-01-14
EP1090915B1 (de) 2009-05-27
DK1090915T3 (da) 2009-07-13

Similar Documents

Publication Publication Date Title
ES2172864T3 (es) 2-metoxibenzofenonas fungicidas.
NO920767L (no) Pyranylcyanoguanidin-derivater
MA27349A1 (fr) Composition cristalline renfermant de l'escitalopram.
FR2691468B1 (fr) 3-(Acyloxyphényl)benzofuran 2 ones comme stabilisants.
DK537289D0 (da) 4h-1-benzopyran-4-on-derivater, deres fremstilling og anvendelse
RS50071B (sr) Novi oblik soli pantoprazola
IL143868A0 (en) Use of 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5-tetramethylene -delta 3-dihydrofurane-2-on for controlling the white fly
DE69813605D1 (de) Benzofuranderivate
KR950017992A (ko) 알프조신 염산염의 2수화물
CY1110062T1 (el) Πολυμορφικη μορφη β της 3-(κυκλοπροπυλμεθοξυ)4- [ -4-(μεθυλσουλφονυλ)φαινυλ]-5,5-διμεθυλ-5η-φουραν-2-ονης
DE60006825D1 (de) Serotonerge benzofurane
DE69818261D1 (en) Hydroxycyclopentanone
DE69939424D1 (de) Parfümierte Waschmitteltablette
DK1240163T3 (da) 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler
NO983285L (no) Pyrido-1,2,4-tiadiazin- og pyrido-1,4-tiazinderivater, deres fremstilling og anvendelse
ES2195500T3 (es) Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes.
ATE242227T1 (de) Tetrahydrofuranderivate
AR026673A1 (es) Benzoilpirazoles sustituidos por 3-(4,5-dihidroisoxazol-3-ilo)
DE59703836D1 (de) Herstellung von Salzen der 6,8-Bis(amidiniumthio)-octansäure
DE59002172D1 (de) Neue 1,3-oxazine.
DK0539330T3 (da) Fremgangsmåde til fremstilling af substituerede indoler
CY1110529T1 (el) Παρασκευη ν-υποκατεστημενων 2,7-διαλκυλο-4-υδροξυ-5-αμινο-8-αρυλοοκτανοϋλαμιδιων
MA24447A1 (fr) Pour une variete de rosier intermediaire a fleurs doubles rose clair. variete "febesa"
JPS53147545A (en) Electrographic stencil paper

Legal Events

Date Code Title Description
8364 No opposition during term of opposition